DGAP-News 345 0 Kommentare UMS United Medical Systems International AG i.L.: UMS AG reports on first 9 months 2016 / 17

DGAP-News: UMS United Medical Systems International AG / Key word(s): 9-month figures/9-month figures

UMS United Medical Systems International AG i.L.: UMS AG reports on first 9 months 2016 / 17

14.03.2017 / 10:00

The issuer is solely responsible for the content of this announcement.

UMS AG reports on first 9 months 2016 / 17

Hamburg, March 14, 2017. UMS United Medical Systems International AG i.L. (UMS, ISIN DE 0005493654 / WKN 549365) reported today on the first 9 months of the second year of liquidation. The expenses incurred were largely covered by the liquidation provision, so that profit of EUR 6k was generated from interest income.

As in the comparable period in the previous year, earnings per share amounted to EUR 0.00, while cash in banks fell from EUR 15.4 million to EUR 1.8 million because of the distributions made in the first 9 months of the second year of liquidation. An additional EUR 0.7 million was paid because of the preliminary decisions in the ongoing VAT audit. Equity thus amounts to EUR 2.4 million, following EUR 14.8 million at the beginning of the first 9 months. The equity ratio thus amounted to 78%, down from 93% at May 1, 2016.

The entire report can be downloaded from the Company's website at www.umsag.com.

About UMS International AG

UMS International AG is a corporation listed in the Prime Standard segment of Deutsche Börse AG. The Company sold its interest in United Medical Systems (DE), Inc. and thus essentially all its assets on August 14, 2014. The shareholders agreed to this sale at the special meeting held on September 25, 2014. The agreement was consummated on November 11, 2014. Now that the assets have been sold, the purpose of the Company is to manage its own assets.

At the shareholders meeting 27^th April 2015 the shareholders resolved to dissolve the company as of April 30, 2015.

Contact

Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail:

investor@umsag.com

14.03.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	UMS United Medical Systems International AG
	Borsteler Chaussee 53
	22453 Hamburg
	Germany
Phone:	+49 (0)40 - 500 177 - 00
Fax:	+49 (0)40 - 500 177 - 77
E-mail:	investor@umsag.com
Internet:	www.umsag.com
ISIN:	DE0005493654
WKN:	549365
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange